Patent · US Active

Chimeric flavivirus lyssavirus vaccines

US12070494B2 · kind B2 · utility

0Cited by

1References

23Claims

0Family size

Assignee

Katholieke Universiteit Leuven · BE

Inventors

Kai Dallmeier · Kessel-Lo, BE
Niraj Kumar Mishra · Bengaluru, IN
Johan Neyts · Namur, BE
Lorena Sanchez · Wijgmaal, BE

Key dates

Filing date	Sep 6, 2019
Grant date	Aug 27, 2024
Priority date	—
Expiry date	Jun 7, 2041

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention describes chimeric Flavivirus constructs comprising lyssavirus G proteins in the E/NS1 intergenic region.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.